ASX - By Stock
|
HZN |
Re:
SP rise to 20cents
|
|
snouty
|
14 |
6.2K |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
14
|
6.2K
|
5
|
|
ASX - By Stock
|
SGR |
Re:
Ann: Response to media articles
|
|
snouty
|
107 |
37K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
107
|
37K
|
1
|
|
ASX - By Stock
|
ASB |
Re:
Ann: Response to media regarding non-binding offer from Hanwha
|
|
snouty
|
84 |
33K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
84
|
33K
|
2
|
|
ASX - By Stock
|
ASB |
Re:
Ann: Response to media regarding non-binding offer from Hanwha
|
|
snouty
|
84 |
33K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
84
|
33K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD US commercialisation & Promarker pipeline update
|
|
snouty
|
63 |
24K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
63
|
24K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
snouty
|
123 |
52K |
6 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
123
|
52K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Suspension from Official Quotation
|
|
snouty
|
69 |
24K |
5 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
69
|
24K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Suspension from Official Quotation
|
|
snouty
|
69 |
24K |
10 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
69
|
24K
|
10
|
|
ASX - By Stock
|
MLD |
Re:
Ann: Pause in Trading
|
|
snouty
|
18 |
6.9K |
0 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
18
|
6.9K
|
0
|
|
ASX - By Stock
|
MLD |
Re:
Ann: Pause in Trading
|
|
snouty
|
18 |
6.9K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
18
|
6.9K
|
2
|
|
ASX - By Stock
|
MLD |
Re:
Ann: Thiess Announces Cash Offer for MACA
|
|
snouty
|
44 |
29K |
0 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
44
|
29K
|
0
|
|
ASX - By Stock
|
MLD |
Re:
Ann: Thiess Announces Cash Offer for MACA
|
|
snouty
|
44 |
29K |
3 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
44
|
29K
|
3
|
|
ASX - By Stock
|
KOV |
Re:
Ann: 30 June 2022 Annual Results - Press Release
|
|
snouty
|
9 |
5.9K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
9
|
5.9K
|
2
|
|
ASX - By Stock
|
LKE |
Re:
LKE towards TOP-5
|
|
snouty
|
24K |
6.6M |
6 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
24K
|
6.6M
|
6
|
|
Charts
|
TER |
Re:
TER
|
|
snouty
|
398 |
183K |
15 |
21/06/22 |
21/06/22 |
Charts
|
398
|
183K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
snouty
|
26K |
12M |
12 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
26K
|
12M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Prospectus for SPP and Placement Options Offer
|
|
snouty
|
198 |
103K |
12 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
198
|
103K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
snouty
|
1.7K |
1.0M |
20 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
1.7K
|
1.0M
|
20
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Hexagon Completes $6.2 Million Placement to Fund Pedirka
|
|
snouty
|
33 |
10K |
4 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
33
|
10K
|
4
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Hexagon Energy Materials Announces Technical Providers
|
|
snouty
|
6 |
4.1K |
7 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
6
|
4.1K
|
7
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm Receives Firm Commitments to Raise $12 million
|
|
snouty
|
41 |
18K |
12 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
41
|
18K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
|
|
snouty
|
146 |
80K |
6 |
10/04/21 |
10/04/21 |
ASX - By Stock
|
146
|
80K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Letter from Leslie
|
|
snouty
|
37 |
17K |
25 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
37
|
17K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Imugene IMU - exciting news ahead
|
|
snouty
|
30 |
19K |
8 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
30
|
19K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Imugene IMU - exciting news ahead
|
|
snouty
|
30 |
19K |
4 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
30
|
19K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial
|
|
snouty
|
302 |
162K |
3 |
27/03/21 |
27/03/21 |
ASX - By Stock
|
302
|
162K
|
3
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Investor Presentation
|
|
snouty
|
84 |
22K |
5 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
84
|
22K
|
5
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Imugene - Charts & Price Action (New thread)
|
|
snouty
|
1.7K |
923K |
12 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
1.7K
|
923K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Why is IMMP up?
|
|
snouty
|
67 |
35K |
8 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
67
|
35K
|
8
|
|
ASX - By Stock
|
HXG |
Re:
On the move Up Up Up
|
|
snouty
|
74 |
27K |
5 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
74
|
27K
|
5
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
snouty
|
2 |
1.3K |
5 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
2
|
1.3K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial
|
|
snouty
|
302 |
162K |
17 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
302
|
162K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted US patent for eftilagimod alpha with a PD-1
|
|
snouty
|
39 |
24K |
20 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
39
|
24K
|
20
|
|
ASX - By Stock
|
TI1 |
Re:
bhp replacement
|
|
snouty
|
4 |
1.4K |
2 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
4
|
1.4K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Overall Survival data from ph IIb AIPAC breast cancer trial
|
|
snouty
|
248 |
115K |
9 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
248
|
115K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER Vaxx shows positive Overall Survival in trial
|
|
snouty
|
254 |
112K |
9 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
254
|
112K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER Vaxx shows positive Overall Survival in trial
|
|
snouty
|
254 |
112K |
33 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
254
|
112K
|
33
|
|
ASX - By Stock
|
TI1 |
Re:
Watcher closely
|
|
snouty
|
156 |
53K |
1 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
156
|
53K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Plexoval II First Dosing and $2.1m R&D Rebate Received
|
|
snouty
|
25 |
8.8K |
18 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
25
|
8.8K
|
18
|
|
ASX - By Stock
|
SPX |
Re:
CRO chart
|
|
snouty
|
2.8K |
953K |
2 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
2.8K
|
953K
|
2
|
|
ASX - By Stock
|
SPX |
Re:
CRO chart
|
|
snouty
|
2.8K |
953K |
9 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
2.8K
|
953K
|
9
|
|
ASX - By Stock
|
SPX |
Proactive interview
|
|
snouty
|
12 |
5.1K |
7 |
01/08/20 |
01/08/20 |
ASX - By Stock
|
12
|
5.1K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
What is happening here.
|
|
snouty
|
82 |
43K |
17 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
82
|
43K
|
17
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Imugene - Fundamentals
|
|
snouty
|
189 |
95K |
14 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
189
|
95K
|
14
|
|
ASX - By Stock
|
IMU Biotech |
Re:
New LC Interview
|
|
snouty
|
27 |
14K |
3 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
27
|
14K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
snouty
|
50 |
25K |
26 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
50
|
25K
|
26
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
snouty
|
50 |
25K |
15 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
50
|
25K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
snouty
|
50 |
25K |
1 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
50
|
25K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
snouty
|
50 |
25K |
6 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
50
|
25K
|
6
|
|
ASX - By Stock
|
IMU |
Laurence Fishburne
|
|
snouty
|
50 |
25K |
35 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
50
|
25K
|
35
|
|